Barclays Issues Pessimistic Forecast for BKV (NYSE:BKV) Stock Price

BKV (NYSE:BKV – Get Free Report) had its price target dropped by equities researchers at Barclays from $36.00 to $33.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s target price points to a potential upside of 73.27% from the stock’s current price.

BKV has been the topic of a number of other research reports. Susquehanna cut their price objective on shares of BKV from $37.00 to $35.00 and set a “positive” rating on the stock in a report on Tuesday, July 21st. Wall Street Zen downgraded BKV from a “sell” rating to a “strong sell” rating in a research note on Saturday, October 17th. Raymond James Financial set a $29.00 target price on BKV in a research report on Tuesday, September 15th. Zacks Research lowered BKV from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 4th. Finally, Weiss Ratings cut BKV from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $33.11.

Check Out Our Latest Stock Analysis on BKV

BKV Stock Down 1.2%

Shares of BKV stock traded down $0.23 on Friday, hitting $19.05. The stock had a trading volume of 53,602 shares, compared to its average volume of 1,188,001. The firm has a market capitalization of $2.06 billion, a price-to-earnings ratio of 8.99 and a beta of 1.13. The stock’s 50 day moving average is $22.16 and its 200-day moving average is $26.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 3.18 and a current ratio of 3.25. BKV has a 52-week low of $17.47 and a 52-week high of $32.81.

BKV (NYSE:BKV – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.02). BKV had a net margin of 12.87% and a return on equity of 6.12%. The firm had revenue of $478.37 million for the quarter, compared to analyst estimates of $395.18 million. As a group, research analysts expect that BKV will post 1.37 earnings per share for the current year.

Insider Activity

In other BKV news, SVP Javier Hinojosa sold 4,952 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $20.91, for a total transaction of $103,546.32. Following the transaction, the senior vice president owned 71,896 shares of the company’s stock, valued at $1,503,345.36. This trade represents a 6.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 1,500 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $25.63, for a total value of $38,445.00. Following the transaction, the chief financial officer directly owned 57,024 shares in the company, valued at approximately $1,461,525.12. This represents a 2.56% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 30,578 shares of company stock valued at $743,536. 2.51% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On BKV

A number of institutional investors have recently made changes to their positions in BKV. First Trust Advisors LP raised its position in shares of BKV by 16.5% during the 3rd quarter. First Trust Advisors LP now owns 649,446 shares of the company’s stock valued at $13,859,000 after acquiring an additional 92,090 shares in the last quarter. HighTower Advisors LLC lifted its stake in BKV by 33.6% during the third quarter. HighTower Advisors LLC now owns 33,043 shares of the company’s stock worth $705,000 after purchasing an additional 8,308 shares during the last quarter. Jefferies Financial Group Inc. acquired a new position in BKV in the third quarter worth $856,000. CenterBook Partners LP boosted its holdings in BKV by 62.1% in the third quarter. CenterBook Partners LP now owns 229,200 shares of the company’s stock worth $4,891,000 after purchasing an additional 87,787 shares during the period. Finally, Covestor Ltd increased its stake in BKV by 36.4% during the third quarter. Covestor Ltd now owns 3,454 shares of the company’s stock valued at $74,000 after purchasing an additional 921 shares during the last quarter.

BKV Company Profile

(Get Free Report)

BKV Corporation is a U.S. energy company focused on natural gas production and related businesses. It operates in the Barnett Shale in Texas and the Marcellus Shale in Pennsylvania, producing natural gas for sale to customers and markets across the region. The company has expanded beyond production into natural gas gathering and processing, natural gas-fired power generation, and carbon capture and sequestration. These activities connect its gas operations with energy delivery and projects intended to reduce emissions.

Further Reading

Analyst Recommendations for BKV (NYSE:BKV)

Receive News & Ratings for BKV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BKV and related companies with MarketBeat.com's FREE daily email newsletter.